Dementia is often accompanied by disturbances in behavior which require treatment with medications. Traditionally, antipsychotics and benzodiazepines have been used. Their modest beneficial effects must be balanced against toxicities such as drug-induced parkinsonism which leads to falls, and worsened cognitive function. Anticonvulsant medications have been used in the past to treat agitated and aggressive behaviors from various conditions. Recent reports attest to their usefulness in treating behavioral problems secondary to dementia. Carbamazepine and divalproex sodium have proven effective in treatment while newer agents like gabapentin may be useful as well. These agents may be preferable because they target a broad variety of symptoms and diseases, are less likely to induce extrapyramidal reactions and some have a low drug interaction profile.
Cummings JL, Mega M.Alzheimer's disease: Etiologies and pathogenesis . Cons Pharm 1996;11(suppl E):8-15.
2.
Zimmer JG, Watson N.Treat A. Behavior problems among patients in skilled nursing facilities. Am J Public Health1984;74:118-21.
3.
Tariot PN, et al.Mental disorders in the nursing home. Am J Psychiatry1993;150:1063-9.
4.
Tune LE, Steele C, Cooper T.Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease. Psychiatry Clin North Am1991;14:353-73.
5.
Morriss RK, et al.Delusions in newly admitted residents of nursing homes. Am J Psychiatry1990;147:299-302.
6.
Jost BC, Grossberg GT.The evolution of psychiatric symptoms in Alzheimer's disease: A natural history study. J Am Geriatr Soc1996;44:1078-81.
7.
Duffy JD, Campbell JJ.The regional prefrontal syndromes: A theoretical and clinical overview. J Neuropsychiatr and Neurosci1994;6:379-87.
8.
Piacente GJ.Aggression . Psychiatr Clin North Am1986:329-39.
9.
Barrett ES.The use of anticonvulsants in aggression and violence. Psychopharmacol Bull1993;29:75-81.
10.
Anton RF, Waid LR, Fossey M, AuBuchon P.Case report of carbamazepine treatment of organic brain syndrome with psychotic features. J Clin Psychopharmacol1986;6:232-4.
11.
Essa M.Carbamazepine in dementia. J Clin Psychopharmacol1986;6:234-6.
12.
Tariot PN, et al.Efficacy and tolerability of carbamazepine for agitation and aggression in dementia . Am J Psychiatry1998;155:54-61.
13.
McElroy SL, Kasckow JW, Lott AD et al. Valproate in the treatment of behavioral agitation of dementia. Psych Annals1996; 26:S474-9.
14.
Lott AD, McElroy SL, Keys MA.Valproate in the treatment of behavioral agitation in elderly patients with dementia. J Neuropsych Clin Neurosci1995 ;7:314-9.
15.
Barratt ES, Stanford MS, Felthous AR, Kent TA.The effects of phenytoin on impulsive and premeditated aggression: A controlled study. J Clin Psychopharmacol1997;17:341-9.
16.
Schmidt B.Potential antiepileptic drugs-Gabapentin. In: Levy R, et al, eds. Antiepileptic Drugs. 3rd ed. New York: Raven Press, 1989:925-35.
17.
White HS.Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs . Epilepsia1999; 40 Suppl 5:S2-10.
18.
Campbell MM.Focus on vigabatrin: A second generation antiepileptic agent for treatment of refractory seizures disorders. Hosp Formul1995;30:143-7.
19.
Marcotte D.Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affective Disorders1998;50:245-51.
20.
Tariot PN, et al.Carbamazepine treatment of agitation in nursing home patients with dementia : A preliminary study. J Am Geriatr Soc1994;42:1160-6.
21.
Chambers CA, et al.Carbamazepine in senile dementia and overactivity: a placebo controlled double-blind trial . IRCS Med Sci1982;10:505-6.
22.
Lemke MR.Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics. J Clin Psychiatry1995;56:354-7.
23.
Patterson JF.A preliminary study of carbamazepine in the treatment of assaultive patients with dementia . J Geriatr Psychiatry Neurol1988;1:21-3.
24.
Gleason RP, Schneider LS.Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. J Clin Psychiatry1990;51:115-8.
25.
Marin D, Greenwald BS.Carbamazepine for aggressive agitation in demented patients during nursing care. Am J Psychiatry1989;146:805.
26.
Leibovici A, Tariot PN.Carbamazepine treatment of agitation associated with dementia. J Geriatr Psychiatry Neurol1988;1:110-2.
27.
Regan WM, Gordon SM.Gabapentin for behavioral agitation in Alzheimer's disease. J Clin Psychopharmacol1997;17:59-60.
28.
Goldenberg G, Kahaner K, Basavaraju N et al. Drugs and Aging1998; 13:183-4.
29.
Roane DM, et al.Treatment of dementia-associated agitation with gabapentin. J Neuropsychiatry Clin Neurosci2000;12:40-3.
30.
Herrmann N, Lanctot K, Myszak M.Effectiveness of gabapentin for the treatment of behavioral disorders in dementia . J Clin Psychopharmacol2000;20(1):90-3.
31.
Porsteinsson AP, et al.An open trial of valproate for agitation in geriatric neuropsychiatric disorders . Am J Geriatr Psychiatry1997;5:344-51.
32.
Herrmann N.Valproic acid treatment of agitation in dementia. Can J Psychiatry1998;43:69-72.
33.
Narayan M, Nelson JC.Treatment of dementia with behavioral disturbances using divalproex or a combination of divalproex and a neuroleptic. J Clin Psychiatry1997;58:351-4.
34.
Sival R, et al.The effect of sodium valproate on disturbed behavior in dementia. J Am Geriatr Soc1994;42:906-7.
35.
Kunik ME, Puryear L, Orengo CA et al. The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances. Int J Geriatr Psychiatry1998; 13:29-34.
36.
Puryear LJ, Kunik ME and Workman R.Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses. J Geriatr Psychiatry Neurol1995 ;8:234-7.
37.
Mellow AM, Solano-Lopez C, Davis S.Sodium valproate in the treatment of behavioral disturbance in dementia. J Geriatr Psych and Neurol1993;6:205-9.
38.
Sandborn WD, Bendfeldt F, Hamdy R.Valproic acid for physically aggressive behavior in geriatric patients. Am J Geriatric Psychiatry1995;3:239-42.
39.
Mazure CM, Druss BG, Cellar JS.Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol. JAmer Geriatr Soc1992;40:914-6.
40.
Home M, Lindley SE.Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes. J Clin Psychiatry1995;56:430-1.
41.
Lindenmayer J-P and Kotsaftis A.Use of sodium valproate in violent and aggressive behaviors : A critical review. J Clin Psychiatry2000; 61:123-8.
42.
Schacter SC, Cramer GW, Thompson GD et al. An evaluation of antiepileptic drug therapy in nursing facilities . J Am Geriatr Soc1998; 46:1137-41.
43.
Nevitt MC.Falls in the elderly:Risk factors and prevention. In: Masdeu JC, Sudarsky L, Wolfson L, eds. Gait Disorders of Aging. Falls and Therapeutic Strategies. Philadelphia: Lippincott-Raven, 1997;13-36.
44.
Tariot PN, et al.Lack of carbamazepine toxicity in frail nursing home patients: A controlled study . J Am Geriatr Soc1995;43:1026-9.
45.
Sobotka JL, Alexander B, Cook BL.A review of carbamazepine's hematologic reactions and monitoring recommendations . Ann Pharmacother1990;24:1214-9.
46.
Tohen M.The adverse effect profile and safety of divalproex. Rev Contemp Pharmacother1995; 6:587-95.
47.
Devinsky O.Cognitive and behavioral effects of antiepileptic drugs. Epilepsia1995; 36 Suppl 2:S46-65.
48.
Meador KJ, Loring DW, Ray PG et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia1999; 40:1279-85.
49.
Spina E, Pisani F, Perucca E.Clinically significant pharmacokinetic drug interactions with carbamazepine . An update. Clin Pharmacokinetics1996 ;31:198-214.
50.
Wong SL, et al.Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics . Clin Pharmacol Therap1996;60:48-53.
51.
Samara EE, et al.Effects of valproate on the pharmacokinetics and pharmacodynamics of lorazepam. J Clin Pharmacol1997;71:442-50.
